AXGN Q1 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$49M+17.4% YoY

Gross Profit

$35M71.9% margin

Operating Income

-$2M-3.4% margin

Net Income

-$4M-7.9% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-1.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$196M

Total Liabilities

$91M

Stockholders' Equity

$105M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$41M	+17.4%
Gross Profit	$35M	$33M	+7.1%
Operating Income	-$2M	-$5M	+63.6%
Net Income	-$4M	-$7M	+42.2%